Category: Market/Novel Tech

Month: 17 Jul 2012

Issue: not yet available

VisionCare Ophthalmic Technologies, Inc. expands access to its implantable miniature telescope for end-stage AMD patients

VisionCare Ophthalmic Technologies Inc., a private company based in Saratoga, California, have announced the US expansion of availability of their implantable miniature telescope. The recently launched ophthalmic medical device, approved for the monocular treatment of end-stage macular degeneration, will now be available in over 30 locations including Los Angeles, Chicago, Honolulu, Atlanta, Denver, New York, Boston, Tucson, Washington, D.C., Salt Lake City, Seattle, St. Louis and Charlotte. The company has facilitated the expansion through the development of teams of multidisciplinary healthcare specialists trained in patient evaluation, surgical treatment and visual rehabilitation to screen patients for eligibility. A website, www.CentraSight.com, additionally outlines the treatment programme for the miniature telescope in addition to other relevant information.

Back to previous

Related News

Gearoid Tuohy

editor

by Dr. Gearóid Tuohy   Dear EURETINA Members,   A very warm welcome to the December 4th, 2017 edition of EURETINA’s web-based digital magazine, “EURETINA Brief”. EURETINA are delighted to continue our delivery of up-to-date summary briefs on a range of topics of interest to retinal clinicians, specialists and researchers across Europe. This resource is […]